Global and Japan T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 CAR-T
  • 1.2.3 TCR
  • 1.2.4 TIL Therapies
• 1.3 Market by Application
  • 1.3.1 Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
  • 1.3.2 Stomach Cancer
  • 1.3.3 Lung Cancer
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Esophagus Cancer
  • 1.3.6 Pancreatic Cancer
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global T-Cell Immunotherapy Market Perspective (2015-2026)
• 2.2 Global T-Cell Immunotherapy Growth Trends by Regions
  • 2.2.1 T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top T-Cell Immunotherapy Players by Market Size
  • 3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2015-2020)
  • 3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
• 3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
• 3.4 Global T-Cell Immunotherapy Market Concentration Ratio
  • 3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2019
• 3.5 Key Players T-Cell Immunotherapy Area Served
• 3.6 Key Players T-Cell Immunotherapy Product Solution and Service
• 3.7 Date of Enter into T-Cell Immunotherapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Immunotherapy Breakdown Data by Type (2015-2026)

• 4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
• 4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)

5 T-Cell Immunotherapy Breakdown Data by Application (2015-2026)

• 5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2015-2020)
• 5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America T-Cell Immunotherapy Market Size (2015-2026)
• 6.2 North America T-Cell Immunotherapy Market Size by Type (2015-2020)
• 6.3 North America T-Cell Immunotherapy Market Size by Application (2015-2020)
• 6.4 North America T-Cell Immunotherapy Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe T-Cell Immunotherapy Market Size (2015-2026)
• 7.2 Europe T-Cell Immunotherapy Market Size by Type (2015-2020)
• 7.3 Europe T-Cell Immunotherapy Market Size by Application (2015-2020)
• 7.4 Europe T-Cell Immunotherapy Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China T-Cell Immunotherapy Market Size (2015-2026)
• 8.2 China T-Cell Immunotherapy Market Size by Type (2015-2020)
• 8.3 China T-Cell Immunotherapy Market Size by Application (2015-2020)
• 8.4 China T-Cell Immunotherapy Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan T-Cell Immunotherapy Market Size (2015-2026)
• 9.2 Japan T-Cell Immunotherapy Market Size by Type (2015-2020)
• 9.3 Japan T-Cell Immunotherapy Market Size by Application (2015-2020)
• 9.4 Japan T-Cell Immunotherapy Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia T-Cell Immunotherapy Market Size (2015-2026)
• 10.2 Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
• 10.3 Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020)
• 10.4 Southeast Asia T-Cell Immunotherapy Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Adaptimmune
  • 11.1.1 Adaptimmune Company Details
  • 11.1.2 Adaptimmune Business Overview
  • 11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
  • 11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2015-2020))
  • 11.1.5 Adaptimmune Recent Development
• 11.2 Altor Bioscience Corporation
  • 11.2.1 Altor Bioscience Corporation Company Details
  • 11.2.2 Altor Bioscience Corporation Business Overview
  • 11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
  • 11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.2.5 Altor Bioscience Corporation Recent Development
• 11.3 Cellectis
  • 11.3.1 Cellectis Company Details
  • 11.3.2 Cellectis Business Overview
  • 11.3.3 Cellectis T-Cell Immunotherapy Introduction
  • 11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.3.5 Cellectis Recent Development
• 11.4 Juno Therapeutics
  • 11.4.1 Juno Therapeutics Company Details
  • 11.4.2 Juno Therapeutics Business Overview
  • 11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
  • 11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.4.5 Juno Therapeutics Recent Development
• 11.5 Kite Pharma
  • 11.5.1 Kite Pharma Company Details
  • 11.5.2 Kite Pharma Business Overview
  • 11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
  • 11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.5.5 Kite Pharma Recent Development
• 11.6 Novartis
  • 11.6.1 Novartis Company Details
  • 11.6.2 Novartis Business Overview
  • 11.6.3 Novartis T-Cell Immunotherapy Introduction
  • 11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.6.5 Novartis Recent Development
• 11.7 Takara Bio
  • 11.7.1 Takara Bio Company Details
  • 11.7.2 Takara Bio Business Overview
  • 11.7.3 Takara Bio T-Cell Immunotherapy Introduction
  • 11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.7.5 Takara Bio Recent Development
• 11.8 Unum Therapeutics
  • 11.8.1 Unum Therapeutics Company Details
  • 11.8.2 Unum Therapeutics Business Overview
  • 11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
  • 11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
  • 11.8.5 Unum Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer